Clinical trial · Interventional
Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
NCT03016364CI-TRIAL-00036703unknownPhase 1 / Phase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oxycodone | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Physicians | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| APP software | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- APP in dosage adjustment
- description
- Through the guidance of APP software, clinical doctors try to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain.
- interventionNames
- Device: APP software
Primary outcomes (1)
- measure
- Numerical Pain Rating Scale
- timeFrame
- upto 8 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * a histologically confirmed diagnosis of Cancer or Sarcoma * advanced patients with severe cancer pain(score \>3) * having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets Exclusion Criteria: * allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids
References
Publications (0)
Data not yet available
No reference posted for this study.